Cogent Biosciences (COGT) Other financing activities (2017 - 2025)

Cogent Biosciences' Other financing activities history runs 6 years deep, the most recent figure standing at $46.6 million for Q4 2025.

• In Q4 2025, Other financing activities changed N/A year-over-year to $46.6 million; the TTM figure through Dec 2025 stood at $48.9 million (changed N/A YoY), while the FY2025 annual figure was $48.9 million, changed N/A from the prior year.
• Other financing activities was $46.6 million for Q4 2025 at Cogent Biosciences, up from $235000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $46.6 million in Q4 2025 to a low of $235000.0 in Q3 2025.
• Historically, Other financing activities has averaged $11.7 million across 4 years, with a median of $10.7 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Other financing activities slipped 0.93% in 2023, then tumbled 93.97% in 2025.
• A 4-year view of Other financing activities shows it stood at $10.8 million in 2022, then decreased by 0.93% to $10.7 million in 2023, then rose by 8.41% to $11.6 million in 2024, then soared by 301.66% to $46.6 million in 2025.
• The last three Other financing activities figures came in at $46.6 million (Q4 2025), $235000.0 (Q3 2025), and $1.4 million (Q2 2025), per Business Quant data.